{"id":31789,"date":"2024-06-06T08:49:26","date_gmt":"2024-06-06T06:49:26","guid":{"rendered":"https:\/\/www.cosinuss.com\/?p=31789"},"modified":"2024-06-06T09:28:29","modified_gmt":"2024-06-06T07:28:29","slug":"cosinuss-joins-dimes-datacc-project-building-the-business-case-for-digital-endpoints-to-revolutionize-clinical-trials","status":"publish","type":"post","link":"https:\/\/www.cosinuss.com\/en\/2024\/06\/06\/cosinuss-joins-dimes-datacc-project-building-the-business-case-for-digital-endpoints-to-revolutionize-clinical-trials\/","title":{"rendered":"cosinuss\u00b0 joins DiME\u2019s DATAcc project “Building the Business Case for Digital Endpoints” to revolutionize clinical trials"},"content":{"rendered":"

New project to boost investment in digital endpoints for clinical trials<\/h2><\/div>

Munich\/Boston (MA), June 6, 2024<\/em> – Digital measures provide clinical trials with unprecedented insights into patients’ real experiences and enhance understanding of various conditions. Recent findings<\/span>1<\/sup><\/a><\/span> show significant cost reductions and financial benefits from using digital endpoints in trials. DATAcc by DiMe launches its new project, “Building the Business Case for Digital Endpoints,” aimed at advancing the adoption of digital health measures in clinical trials. This initiative is set to boost investment in digital measurement by providing comprehensive tools and frameworks to demonstrate the value of digital endpoints. cosinuss\u00b0 has joined the project team, to make a valuable contribution with our deep expertise in mobile or remote vital parameter measurements.<\/p>\n<\/div><\/div><\/div><\/div><\/div>

Innovative patient monitoring technology to collect valuable health data<\/h3><\/div>

cosinuss\u00b0 is contributing its knowledge and expertise in advanced mobile patient monitoring and existing technology to the project. Our core is creating valuable, structured health data with a mobile solution ideal for decentralized studies, enabling patient monitoring from home. We want to provide solutions to seamlessly record, structure and oversee large amounts of qualitative vital data. With the in-ear sensor c-med\u00b0 alpha and the Health\u00b0 software, the most important vital parameters and quality values can be measured and evaluated continuously – remotely or on site. Several studies and projects already show that cosinuss\u00b0 provides high-quality data (e.g. TeleCovid, CO-SI-ONKO). We are proud to support DiME’s goal of creating the business use case for digital endpoints in clinical trials.<\/p>\n<\/div><\/div><\/div><\/div><\/div>

Boosting the adoption of digital endpoints in clinical trials<\/h3><\/div>

Despite their proven cost savings and financial benefits, adoption of digital endpoints has been slow due to unclear value and deployment strategies. DATAcc’s project aims to overcome these challenges by developing resources to help organizations make informed decisions and sustain investments in digital health strategies. The project will establish a value framework, industry benchmarking tools, ROI forecasting models, support organizations in building the business case for digital endpoints in clinical trials, and help organizations optimize financial and operational strategies. \u201cDigital measures can bring significant benefits to clinical research – improving the patient experience, saving costs, and speeding the path to uncover new cures to the issues facing patients today,\u201d said Victoria Bangieva, PhD, Program Director, DiMe. \u201cDespite these benefits and the speed of technology improvement, we see barriers to full acceptance. We\u2019re excited to work with cosinuss\u00b0 to create a set of open source resources to build a business case for greater use of digital endpoints, to advance research and improve the lives of patients.\u201d<\/p>\n<\/div>

More information about the project: Building the Business Case for Digital Endpoints – DATAcc by DiMe<\/a><\/p>\n<\/div><\/div><\/div><\/div><\/div>

About DATAcc<\/h3><\/div>

The Digital Health Measurement Collaborative Community (DATAcc) by the Digital Medicine Society (DiMe) is a collaborative community with the FDA\u2019s Center for Devices and Radiological Health. They provide a forum for collaboration where partners and experts from across the digital health field work to advance the use of digital health measures in research to improve lives.<\/p>\n<\/div>

About cosinuss\u00b0<\/h3><\/div>

Cosinuss GmbH is a certified medical device manufacturer based in Munich that specializes in mobile and continuous monitoring of various vital signs. With more than 15 years of research and development, numerous patents and medically certified products, cosinuss\u00b0 is a pioneer and hidden champion in the field of mobile and continuous vital signs monitoring. cosinuss\u00b0 follows the vision of revolutionizing the monitoring and recording of vital signs in various fields of healthcare.<\/p>\n<\/div><\/div><\/div><\/div><\/div>

Press contact cosinuss\u00b0<\/strong>
\nMelanie Schade
\nPhone: +49 (0)89 740 418 32
\nE-Mail: presse@cosinuss.com<\/a><\/p>\n<\/div>

Download press release: cosinuss\u00b0 DiME DATAcc (PDF)<\/a><\/p>\n<\/div><\/div><\/div><\/div><\/div><\/p>\n

Share this post! \/ Teile diesen Beitrag!<\/div>